Philippe Menu sold $36k of SOPH
Chief Medical Officer at SOPHiA GENETICS SA. 5,000 shares at an average of $7.26, traded Oct 12, 2026, filed Oct 14, 2026.
Score components
This filing reached EDGAR on Oct 14, 2026, so its score and components open to free visitors on Oct 21, 2026. The trade itself, the rows in the filing and the price context are public now.
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001840706-26-000344, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 12, 2026 | SOpen-market sale Ordinary Shares10b5-1 | -5,000 | $7.26 | $36k | 195,993 | 56 min ago |
Related signals
Other insiders at SOPHiA GENETICS SA and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| Pro nowfree Oct 21, 2026 | SOPHiA GENETICS SA | Zhenyu Xu Chief Scientific Officer | $29k 4,000 shares | -1% | |
| Pro nowfree Oct 21, 2026 | SOPHiA GENETICS SA | Jurgi Camblong Executive Chairman | $62k 8,500 shares | -0% | |
| 17Weak | SOPHiA GENETICS SA | George Cardoza Chief Financial Officer | $13k 1,592 shares | -1% | |
| 30Weak | SOPHiA GENETICS SA | Jurgi Camblong Executive Chairman | $327k 40,172 shares | -1% | |
| 17Weak | SOPHiA GENETICS SA | Philippe Menu Chief Medical Officer | $60k 7,394 shares | -4% | |
| 29Weak | SOPHiA GENETICS SA | Ross Muken Chief Executive Officer | $80k 9,838 shares | -1% | |
| 30Weak | SOPHiA GENETICS SA | Kevin Puylaert Chief Sales Officer | $1,737 216 shares | -0% | |
| 17Weak | SOPHiA GENETICS SA | Zhenyu Xu Chief Scientific Officer | $60k 7,394 shares | -1% | |
| 16Weak | SOPHiA GENETICS SA | Abhimanyu Verma Chief Technology Officer | $43k 5,284 shares | -3% | |
| 16Weak | SOPHiA GENETICS SA | Manuela Valente Chief People Officer | $34k 4,240 shares | -2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.